{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:21:48Z","timestamp":1790655708477,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["2018-078"],"award-info":[{"award-number":["2018-078"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["2018-079"],"award-info":[{"award-number":["2018-079"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018050","name":"Centre de Recherche en Cancerologie de Marseille","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.tranon.2025.102421","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T05:08:16Z","timestamp":1747458496000},"page":"102421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma"],"prefix":"10.1016","volume":"57","author":[{"given":"Analia Meilerman","family":"Abuelafia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Santofimia-Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3462-7904","authenticated-orcid":false,"given":"Matias","family":"Estaras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8932-716X","authenticated-orcid":false,"given":"Daniel","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3084-2500","authenticated-orcid":false,"given":"Eduardo","family":"Chuluyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5463-789X","authenticated-orcid":false,"given":"Gwen","family":"Lomberk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raul","family":"Urrutia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Dusetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Fraunhoffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1822-2237","authenticated-orcid":false,"given":"Juan","family":"Iovanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2025.102421_bib0001","article-title":"Estimated projection of US cancer incidence and death to 2040","volume":"4","author":"Rahib","year":"2021","journal-title":"JAMA Netw. Open. Am. Med. Assoc."},{"key":"10.1016\/j.tranon.2025.102421_bib0002","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","article-title":"Therapeutic developments in pancreatic cancer: current and future perspectives","volume":"15","author":"Neoptolemos","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"key":"10.1016\/j.tranon.2025.102421_bib0003","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tranon.2025.102421_bib0004","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.tranon.2025.102421_bib0005","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1158\/1078-0432.CCR-11-3114","article-title":"The pancreas cancer microenvironment","volume":"18","author":"Feig","year":"2012","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.tranon.2025.102421_bib0006","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMra0901557","article-title":"Pancreatic cancer","volume":"362","author":"Hidalgo","year":"2010","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.tranon.2025.102421_bib0007","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.tranon.2025.102421_bib0008","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1126\/science.1171362","article-title":"Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer","volume":"324","author":"Olive","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.tranon.2025.102421_bib0009","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/s41571-022-00668-4","article-title":"Senescence and cancer \u2014 role and therapeutic opportunities","volume":"19","author":"Schmitt","year":"2022","journal-title":"Nat. Rev. Clin. Oncol"},{"key":"10.1016\/j.tranon.2025.102421_bib0010","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/jnci\/djq364","article-title":"Therapy-induced senescence in cancer","volume":"102","author":"Ewald","year":"2010","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1016\/j.tranon.2025.102421_bib0011","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc2772","article-title":"Senescence in tumours: evidence from mice and humans","volume":"10","author":"Collado","year":"2010","journal-title":"Nat. Rev. Cancer."},{"key":"10.1016\/j.tranon.2025.102421_bib0012","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/jnci\/djab064","article-title":"Therapy-Induced Senescence: opportunities to Improve Anticancer Therapy","volume":"113","author":"Prasanna","year":"2021","journal-title":"J. Natl. Cancer Inst"},{"key":"10.1016\/j.tranon.2025.102421_bib0013","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3389\/fonc.2017.00278","article-title":"The dual role of cellular senescence in Developing tumors and their response to cancer Therapy","volume":"7","author":"Schosserer","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.tranon.2025.102421_bib0014","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.cellbi.2008.04.021","article-title":"Tumor cells can escape DNA-damaging cisplatin through DNA endoreduplication and reversible polyploidy","volume":"32","author":"Puig","year":"2008","journal-title":"Cell Biol. Int"},{"key":"10.1016\/j.tranon.2025.102421_bib0015","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41514-024-00168-y","article-title":"The paradox of senescent-marker positive cancer cells: challenges and opportunities","volume":"10","author":"O\u2019Sullivan","year":"2024","journal-title":"NPJ Aging"},{"key":"10.1016\/j.tranon.2025.102421_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225586","article-title":"Upregulation of ERK phosphorylation in rat dorsal root ganglion neurons contributes to oxaliplatin-induced chronic neuropathic pain","volume":"14","author":"Maruta","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.tranon.2025.102421_bib0017","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.2147\/OTT.S108929","article-title":"CTGF enhances resistance to 5-FU-mediating cell apoptosis through FAK\/MEK\/ERK signal pathway in colorectal cancer","volume":"9","author":"Yang","year":"2016","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.tranon.2025.102421_bib0018","first-page":"746","article-title":"ERK activation and autophagy impairment are central mediators of irinotecan-induced steatohepatitis","volume":"67","author":"Mahli","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.tranon.2025.102421_bib0019","doi-asserted-by":"crossref","first-page":"19555","DOI":"10.1074\/jbc.M011164200","article-title":"Paclitaxel induces prolonged activation of the Ras\/MEK\/ERK pathway independently of activating the programmed cell death machinery","volume":"276","author":"Okano","year":"2001","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.tranon.2025.102421_bib0020","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1111\/bph.13725","article-title":"5-fluorouracil causes endothelial cell senescence: potential protective role of glucagon-like peptide 1","volume":"174","author":"Altieri","year":"2017","journal-title":"Br. J. Pharmacol"},{"key":"10.1016\/j.tranon.2025.102421_bib0021","doi-asserted-by":"crossref","first-page":"409","DOI":"10.18632\/oncotarget.2774","article-title":"Irinotecan treatment and senescence failure promote the emergence of more transformed and invasive cells that depend on anti-apoptotic Mcl-1","volume":"6","author":"Jonch\u00e8re","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.tranon.2025.102421_bib0022","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41419-018-0303-9","article-title":"Senescence-associated secretory factors induced by cisplatin in melanoma cells promote non-senescent melanoma cell growth through activation of the ERK1\/2-RSK1 pathway","volume":"9","author":"Sun","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tranon.2025.102421_bib0023","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2018.08.033","article-title":"Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features","volume":"155","author":"Puleo","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tranon.2025.102421_bib0024","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41586-023-06130-4","article-title":"Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours","volume":"618","author":"Gavish","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2025.102421_bib0025","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41588-022-01134-8","article-title":"Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment","volume":"54","author":"Hwang","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/j.tranon.2025.102421_bib0026","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41420-020-0286-z","article-title":"Convergence of therapy-induced senescence (TIS) and EMT in multistep carcinogenesis: current opinions and emerging perspectives","volume":"6","author":"Faheem","year":"2020","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.tranon.2025.102421_bib0027","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.molonc.2013.02.002","article-title":"Genetically engineered mouse models of pancreatic adenocarcinoma","volume":"7","author":"Guerra","year":"2013","journal-title":"Mol. Oncol"},{"key":"10.1016\/j.tranon.2025.102421_bib0028","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.omto.2019.07.005","article-title":"ROS\/KRAS\/AMPK Signaling Contributes to Gemcitabine-Induced Stem-like Cell Properties in Pancreatic Cancer","volume":"14","author":"Zhao","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.tranon.2025.102421_bib0029","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.canlet.2018.09.013","article-title":"KRAS targeting antibody synergizes anti-cancer activity of gemcitabine against pancreatic cancer","volume":"438","author":"Kang","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.tranon.2025.102421_bib0030","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/j.1349-7006.2007.00506.x","article-title":"K-ras oncogene silencing strategy reduces tumor growth and enhances gemcitabine chemotherapy efficacy for pancreatic cancer treatment","volume":"98","author":"R\u00e9jiba","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.tranon.2025.102421_bib0031","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99263","article-title":"Generation and testing of clinical-grade exosomes for pancreatic cancer","volume":"3","author":"Mendt","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.tranon.2025.102421_bib0032","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1158\/2159-8290.CD-24-0177","article-title":"Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer","volume":"14","author":"Dilly","year":"2024","journal-title":"Cancer Discov"},{"key":"10.1016\/j.tranon.2025.102421_bib0033","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/acs.jmedchem.1c01688","article-title":"Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tranon.2025.102421_bib0034","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1158\/1078-0432.CCR-15-0485","article-title":"The MEK1\/2 Inhibitor Pimasertib Enhances Gemcitabine Efficacy in Pancreatic Cancer Models by Altering Ribonucleotide Reductase Subunit-1 (RRM1)","volume":"21","author":"Vena","year":"2015","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.tranon.2025.102421_bib0035","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/0300060512474128","article-title":"ERK1\/2 activity contributes to gemcitabine resistance in pancreatic cancer cells","volume":"41","author":"Zheng","year":"2013","journal-title":"J. Int. Med. Res"},{"key":"10.1016\/j.tranon.2025.102421_bib0036","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1158\/0008-5472.CAN-23-1313","article-title":"Dual Inhibition of KRASG12D and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma","volume":"83","author":"Gulay","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.tranon.2025.102421_bib0037","article-title":"KRAS12-inhibitor-based combination therapies for pancreatic cancer: insights from drug screening","author":"Tapia Contreras","year":"2024","journal-title":"Mol. Oncol. [Internet]"},{"key":"10.1016\/j.tranon.2025.102421_bib0038","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.ejca.2014.04.024","article-title":"A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas","volume":"50","author":"Infante","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tranon.2025.102421_bib0039","article-title":"Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage response","volume":"2024","author":"H\u00f6fer","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.tranon.2025.102421_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.101974","article-title":"KRAS G12C Game of Thrones, which direct KRAS inhibitor will claim the iron throne?","volume":"84","author":"Nagasaka","year":"2020","journal-title":"Cancer Treat. Rev"},{"key":"10.1016\/j.tranon.2025.102421_bib0041","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1158\/2159-8290.CD-22-1066","article-title":"Efficacy of a Small-Molecule Inhibitor of KrasG12D in Immunocompetent Models of Pancreatic Cancer","volume":"13","author":"Kemp","year":"2023","journal-title":"Cancer Discov"},{"key":"10.1016\/j.tranon.2025.102421_bib0042","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-023-06123-3","article-title":"Pan-KRAS inhibitor disables oncogenic signalling and tumour growth","volume":"619","author":"Kim","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2025.102421_bib0043","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/bs.acr.2023.02.004","article-title":"Targeting KRAS in pancreatic cancer: emerging therapeutic strategies","volume":"159","author":"Khan","year":"2023","journal-title":"Adv. Cancer Res"},{"key":"10.1016\/j.tranon.2025.102421_bib0044","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-4939-6670-7_3","article-title":"Cellular Model of p21-Induced Senescence","volume":"1534","author":"Shtutman","year":"2017","journal-title":"Methods Mol. Biol"},{"key":"10.1016\/j.tranon.2025.102421_bib0045","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/hed.21440","article-title":"Co-overexpression of p21 and Ki-67 in head and neck squamous cell carcinoma relative to a significantly poor prognosis","volume":"33","author":"Fischer","year":"2011","journal-title":"Head Neck"},{"key":"10.1016\/j.tranon.2025.102421_bib0046","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1242\/dev.007047","article-title":"Zeb1 links epithelial-mesenchymal transition and cellular senescence","volume":"135","author":"Liu","year":"2008","journal-title":"Development"},{"key":"10.1016\/j.tranon.2025.102421_bib0047","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41586-019-1694-1","article-title":"The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity","volume":"575","author":"Canon","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2025.102421_bib0048","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1038\/s41591-022-02007-7","article-title":"Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor","volume":"28","author":"Hallin","year":"2022","journal-title":"Nat. Med"},{"key":"10.1016\/j.tranon.2025.102421_bib0049","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nrd3579","volume":"10","author":"Flaherty","year":"2011","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1016\/j.tranon.2025.102421_bib0050","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/s12885-021-08388-1","article-title":"Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition","volume":"21","author":"Ramaker","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.tranon.2025.102421_bib0051","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1038\/s41467-023-40132-0","article-title":"The intensities of canonical senescence biomarkers integrate the duration of cell-cycle withdrawal","volume":"14","author":"Ashraf","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.tranon.2025.102421_bib0052","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.ejca.2014.01.011","article-title":"Autophagy is needed for the growth of pancreatic adenocarcinoma and has a cytoprotective effect against anticancer drugs","volume":"50","author":"Hashimoto","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tranon.2025.102421_bib0053","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nature16187","article-title":"Autophagy maintains stemness by preventing senescence","volume":"529","author":"Garc\u00eda-Prat","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2025.102421_bib0054","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/15548627.2016.1158373","article-title":"Autophagy is a key factor in maintaining the regenerative capacity of muscle stem cells by promoting quiescence and preventing senescence","volume":"12","author":"Wen","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.tranon.2025.102421_bib0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.yjmcc.2024.08.001","article-title":"Suppression of autophagy induces senescence in the heart","volume":"195","author":"Zhai","year":"2024","journal-title":"J. Mol. Cell Cardiol"},{"key":"10.1016\/j.tranon.2025.102421_bib0056","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/bs.acr.2021.02.001","article-title":"Autophagy and senescence, converging roles in pathophysiology as seen through mouse models","volume":"150","author":"Young","year":"2021","journal-title":"Adv. Cancer Res"},{"key":"10.1016\/j.tranon.2025.102421_bib0057","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1002\/1878-0261.13269","article-title":"Autophagy at the intersection of aging, senescence, and cancer","volume":"16","author":"Cassidy","year":"2022","journal-title":"Mol. Oncol"},{"key":"10.1016\/j.tranon.2025.102421_bib0058","doi-asserted-by":"crossref","first-page":"607","DOI":"10.14348\/molcells.2017.0151","article-title":"Autophagy Is Pro-Senescence When Seen in Close-Up, but Anti-Senescence in Long-Shot","volume":"40","author":"Kwon","year":"2017","journal-title":"Mol. Cells"},{"key":"10.1016\/j.tranon.2025.102421_bib0059","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Meth"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325001524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325001524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T03:14:52Z","timestamp":1747970092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325001524"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":59,"alternative-id":["S1936523325001524"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102421","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.04.13.648164","asserted-by":"object"}]},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of Neoplasia Press, Inc.","name":"copyright","label":"Copyright"}],"article-number":"102421"}}